Get started
Author

Frédéric Massicotte

Observed names: F Massicotte, F. Massicotte, Frederic Massicotte, Massicotte, Frédéric
OpenAlex ID: A5057396332
Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients
2002 · F. Massicotte, D. Lajeunesse, et al. · Osteoarthritis and Cartilage · 181
PDF
Mammalian chitinase-like proteins
1999 · Gilles Bleau, Frédéric Massicotte, et al. · Birkhäuser Basel eBooks · 74
Study of the role of leukotriene B4 in abnormal function of human subchondral osteoarthritis osteoblasts: Effects of cyclooxygenase and/or 5‐lipoxygenase inhibition
2002 · Yosabeth Paredes, Frédéric Massicotte, et al. · Arthritis & Rheumatism · 73
Endogenous Prostaglandin E2 and Insulin-like Growth Factor 1 Can Modulate the Levels of Parathyroid Hormone Receptor in Human Osteoarthritic Osteoblasts
2001 · George Hilal, Frédéric Massicotte, et al. · Journal of Bone and Mineral Research · 70
Human Adult Chondrocytes Express Hepatocyte Growth Factor (HGF) Isoforms but Not HGF: Potential Implication of Osteoblasts on the Presence of HGF in Cartilage
2003 · Melanie Guévremont, Johanne Martel-Pelletier, et al. · Journal of Bone and Mineral Research · 69
Modulation of insulin-like growth factor 1 levels in human osteoarthritic subchondral bone osteoblasts
2005 · Frédéric Massicotte, Julio Cesar Fernandes, et al. · Bone · 66
Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts
2006 · Frédéric Massicotte, Isabelle Aubry, et al. · Arthritis Research & Therapy · 52
PDF
Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander
2003 · D. Lajeunesse, F. Massicotte, et al. · Modern Rheumatology · 44
Subchondral bone sclerosis in osteoarthritis: not just an innocent bystander
2003 · D. Lajeunesse, F. Massicotte, et al. · Modern Rheumatology · 12
Ab0740 Use of Secukinumab in Patients With Psoriatic Arthritis. Impacts of Combination With Methotrexate
2019 · Denis Choquette, Louis Bessette, et al. · Annals of the Rheumatic Diseases · 4
PDF
Fri0084 the Impact of Il-6 and Tnf Inhibitors on Hemoglobin Levels: an Analysis From Rhumadata® Clinical Database and Registry
2019 · Denis Choquette, Louis Bessette, et al. · Annals of the Rheumatic Diseases · 4
PDF
Sat0120 Comparative Effectiveness of Tofacitinib and Tnf Inhibitors Since 2014. Impact of Combination With Methotrexate
2019 · Denis Choquette, Louis Bessette, et al. · Annals of the Rheumatic Diseases · 3
PDF
Which advanced treatment should be used following the failure of a first-line anti-TNF in patients with rheumatoid arthritis? 15 years of evidence from the Quebec registry RHUMADATA
2024 · Denis Choquette, Boulos Haraoui, et al. · Lara D. Veeken · 2
PDF
Ab0337 Tofacitinib Monotherapy or Combined With Methotrexate in Patients With Rheumatoid Arthritis Show Similar Retention Over Four Years. Report From Rhumadata ®
2020 · D. Choquette, L. Bessette, et al. · Annals of the Rheumatic Diseases · 2
PDF
FRI0230 Retention rates of tnf inhibitors and abatacept used as a first biologic dmard in the treatment of rheumatoid arthritis: 8 years of experience from the rhumadata® registry
2017 · D Choquette, L Bessette, et al. · Annals of the Rheumatic Diseases · 2
PDF
THU0034 Use of Rituximab Compared To Anti-Tnf Agents as Second and Third-Line Therapy in Patients with Rheumatoid Arthritis. A 6-Year Follow-Up Report from The Rhumadata® Clinical Database and Registry
2016 · J.-P. Raynauld, L. Bessette, et al. · Annals of the Rheumatic Diseases · 1
THU0035 Six Years Tocilizumab Use in Patients with Rheumatoid Arthritis with One Previous anti-TNF Agent Exposure: Comparison with Adalimumab and Etanercept from The Provincial Electronic Database and Registry Rhumadata®
2016 · L. Bessette, J. Brown, et al. · Annals of the Rheumatic Diseases · 1
Hepatocyte growth factor in osteoarthritis: when bone and cartilage decide to have a chat
2003 · P Reboul, M Guévremont, et al. · Arthritis Research · 1
PDF
Pos0057 Which Advanced Treatment Should Be Used Following the Failure of a First-line Anti-tnf in Patients With Rheumatoid Arthritis? 15 Years of Evidence From the Quebec Registry Rhumadata™
2023 · D. Choquette, L. Bessette, et al. · Annals of the Rheumatic Diseases
PDF
Fri0331 Comparison of the Therapeutic Trajectories of Patients With Oligo and Polyarticular Psoriatic Arthritis. a Report From the Rhumadata® Clinical Database and Registry
2020 · D. Choquette, L. Choquette Sauvageau, et al. · Annals of the Rheumatic Diseases
PDF
Sat0140 Comparative Effectiveness of Tofacitinib and Non-tnf Agents Since 2014. Impact of Combination With Methotrexate
2019 · Denis Choquette, Louis Bessette, et al. · Annals of the Rheumatic Diseases
PDF
AB0397 Abatacept shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry
2017 · D Choquette, L Bessette, et al. · Annals of the Rheumatic Diseases
PDF
SAT0195 Rituximab shows better sustainability than tnf inhibitors when used following initial biologic dmard failure in the treatment of rheumatoid arthritis: 8 years of real-world observations from the rhumadata® clinical database and registry
2017 · D Choquette, L Bessette, et al. · Annals of the Rheumatic Diseases
PDF
FRI0120 The Incidence of Herpes Zoster (HZ) in A Population of Patients with Inflammatory Arthritis: A 12-Year Analysis from The Rhumadata Clinical Database and Registry
2016 · B. Haraoui, L. Bessette, et al. · Annals of the Rheumatic Diseases
Faculty Opinions recommendation of Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis.
2012 · Johanne Martel-Pelletier, Frederic Massicotte · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
Works count: 37
Citation count: 661
H-index: 9
I10-index: 9
Year
Topic
Type